Consequently, infarct size and cardiac function was not altered in FIPI-treated mice as observed for PLD1 deficient mice that display enhanced infarct size and declined ejection fraction and fractional shortening following myocardial ischemia (Schonberger et al., 2014). The gene discussed is PLD1; the disease is myocardial ischemia.